Literature DB >> 8374610

Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats.

C Klett1, W Hellmann, E Hackenthal, D Ganten.   

Abstract

Local or tissue renin angiotensin systems are thought to participate in cardiovascular regulation. However, little information is available on the mechanisms by which renin and angiotensinogen synthesis and secretion are regulated in these tissues. In view of the importance of steroid hormones in the regulation of hepatic angiotensinogen, we have examined the effects of dexamethasone, ethinyl estradiol, or dihydrotestosterone on angiotensinogen gene expression in peripheral or cerebral tissues of Wistar Kyoto (WKY) or spontaneously hypertensive rats (SHR). Following a single injection of dexamethasone (7 mg/kg) the concentrations of angiotensinogen mRNA increased in nearly all organs examined. The differences to controls were higher in SHR than in WKY. Dexamethasone in low doses (10 micrograms/kg/day) given for 10 days did not alter angiotensinogen mRNA or blood pressure in control animals, but increased both parameters in the hypertensive strain. The response to a single dose of ethinyl estradiol (3 mg/kg) was not as uniform as that to dexamethasone, and a tendency for a higher sensitivity was found in SHR. High stimulation rates were found in liver and kidneys of both strains. A single dose of dihydrotestosterone (10 mg/kg) did not significantly affect angiotensinogen mRNA in any organ. Only when a high dose of 50 mg/kg was given daily for 20 days, was angiotensinogen mRNA increased in some tissues. These data indicate that glucocorticoids and estrogens participate in the regulation of angiotensinogen gene expression in several extrahepatic tissues. The higher sensitivity to glucocorticoids in SHR may be relevant for the development of hypertension in this strain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374610     DOI: 10.3109/10641969309041637

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

1.  Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study.

Authors:  Catherine Kim; Ana C Ricardo; Edward J Boyko; Costas A Christophi; Marinella Temprosa; Karol E Watson; Xavier Pi-Sunyer; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

Review 2.  Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

Authors:  Licy L Yanes Cardozo; Damian G Romero; Jane F Reckelhoff
Journal:  Physiology (Bethesda)       Date:  2017-09

3.  A single pill to treat postmenopausal hypertension? Not yet.

Authors:  Licy L Yanes; Damian G Romero; Radu Iliescu; Jane F Reckelhoff
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats.

Authors:  Licy L Yanes; Julio C Sartori-Valinotti; Radu Iliescu; Damian G Romero; Lorraine C Racusen; Huimin Zhang; Jane F Reckelhoff
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-11

5.  Circulating and intrarenal renin-angiotensin systems in healthy men and nonpregnant women.

Authors:  Kirsty G Pringle; Shane D Sykes; Eugenie R Lumbers
Journal:  Physiol Rep       Date:  2015-10

6.  Testosterone influences renal electrolyte excretion in SHR/y and WKY males.

Authors:  Jonathan Toot; Cathy Jenkins; Gail Dunphy; Shannon Boehme; Mike Hart; Amy Milsted; Monte Turner; Daniel Ely
Journal:  BMC Physiol       Date:  2008-03-26

7.  Decidualisation of human endometrial stromal cells is associated with increased expression and secretion of prorenin.

Authors:  Eugenie R Lumbers; Yu Wang; Sarah J Delforce; Celine Corbisier de Meaultsart; Philip C Logan; Murray D Mitchell; Kirsty G Pringle
Journal:  Reprod Biol Endocrinol       Date:  2015-11-25       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.